The persistence of TB is a reminder that medical solutions alone are not enough. Renier Coetzee and Ingrid Schoeman write that the disease thrives in conditions shaped by social injustice, including poverty, overcrowded housing, under-resourced health systems, and unequal access to care.
The only tuberculosis vaccine we have is a century old and offers only limited efficacy in children. With leading South African researchers involved in the pivotal clinical trials of three new tuberculosis vaccine candidates, we are on the verge of a major breakthrough, writes Associate Professor Angelique Kany Kany Luabeya.
The new government TB dashboard is a step forward for transparency and accountability in South Africa’s response to the ancient, but still deadly, disease. It is critical that we use it wisely to boost our testing efforts, argues a group of South Africa’s leading TB activists ahead of World TB Day on March 24th.
Universal health coverage cannot succeed with fragmented systems, weak data, and largely symbolic participation. A recent court-ordered pause to NHI implementation offers a chance to build the foundations properly, argue Dr Haseena Majid and Professor Mogie Subban.
Funding cuts over the last year or so have created a crisis for multilateral health institutions. Which institutions emerge from this crisis, and in what form, will have real consequences for the health of people in South Africa, argues Spotlight editor Marcus Low.
Maryke Bezuidenhout is constantly on the road in rural, northern KwaZulu-Natal visiting and helping people with disabilities where they live. As part of Spotlight’s new Rural Health Heroes series, writer Sue Segar and photographer Thom Pierce tagged along with her.
Get to know South Africa’s malaria experts as they outrun hitchhiking mosquitoes and pollution-hardy bugs while navigating a regional funding collapse and a spiralling climate crisis. Joan van Dyk reports.
Antiretroviral therapy has shifted HIV from a fatal to a chronic condition. But neuropsychiatrists say it is imperative for people living with the virus to start treatment immediately as the “duration of untreated exposure” may cause irreversible brain damage and impact long-term cognitive health. Biénne Huisman reports.
Individual rare diseases impact only a very small fraction of people, but collectively they are estimated to affect over three million in South Africa. As we mark International Rare Disease Day on 28 February, Elna Schütz assesses the state of play with rare diseases in the country.
A cutting-edge, South African-led HIV vaccine trial built on decades of research recently kicked off in Cape Town. Elri Voigt unpacks what exactly is being studied, and how the resilience, tenacity and urgency of a group of dedicated South African researchers made it possible.
In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand Rand a month. In the second article of a Spotlight special series, Catherine Tomlinson looks at the medical need for these medicines in the country and what it would take for government to provide them in the public sector.
District managers in South Africa’s public healthcare system currently have to juggle funding from multiple government budget lines, each with different strings attached. To improve district health services, we urgently need to simplify and integrate these funding flows, argues Russell Rensburg.
